FDA User Fee Bill Up For Final Senate Action After House Passage
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate is last step before the bill goes to the president; Rep. Dingell laments that legislators were “closer than ever before” on a tracking agreement but did not quite make it.
You may also be interested in...
Budget Reductions Target FDA Field Operations
President Obama’s fiscal 2016 budget request includes cuts to “low priority” enforcement, surveillance and other activities in the FDA human drugs and biologics programs, but still increases drug and biologics program budgets overall.
Budget Reductions Target FDA Field Operations
President Obama’s fiscal 2016 budget request includes cuts to “low priority” enforcement, surveillance and other activities in the FDA human drugs and biologics programs, but still increases drug and biologics program budgets overall.
FDA Field Operations Would Endure Reductions Under Budget
President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.